M.Sc. Karianne Risberg - from Øystein Fodstad's group at the Department of Tumor Biology - will give her trial lecture on the subject "Preclinical testing of anticancer drugs in vitro and in vivo: predictive power and methodological issues" on Wednesday May 5th at 10.15.
She will defend her PhD thesis - entitled "Immunotoxins in targeted therapy of cancer – a study in malignant melanoma cells" at 13.15 on the same day.
Venue for both events: The Auditorium in the New Research Building (K building), Montebello, Oslo
From major journals, first or last author from the Institute for Cancer Research
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
J Immunol, 209 (10), 2042-2053
Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
Int J Epidemiol (in press)
Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair
EMBO J, e112677 (in press)